E. Kerem (Jerusalem, Israel), R. H. Ersu (Istambul, Turkey)
Distinctive CFTR gene mutations found in Japanese individuals with cystic fibrosis
K. Yoshimura, C. Anzai, S. Sakamoto, M. Kawabata, K. Kishi, E. Tsuboi, S. Homma, Y. Eto (Tokyo, Japan)
|   |
Newly acquired pseudomonas aeruginosa (P.a.) in Belgian CF-patients: does the patients‘ P.a. genotype correlate with environmental genotypes?
S. Van daele, M. Vaneechoutte, F. Haerynck, G. Claeys, F. De Baets (Gent, Belgium)
| |
Weekly nebulisation of liposomal amphotericin B for the treatment of endobronchial aspergillus fumigatus infection in cystic fibrosis
S. J. Phaff, E. J. Ruigrok, T. M. van der Zanden, H. A. Tiddens (Rotterdam, Amsterdam, The Netherlands)
| |
Arginase in patients with cystic fibrosis airway disease
H. Grasemann, R. Schwirtz, K. Racké, F. Ratjen (Essen, Bonn, Germany)
| |
Urinary desmosines: a potential non-invasive marker of early tissue destruction in young children with cystic fibrosis
S. Brennan, K. R. Winfield, N. Kent, P. D. Sly (Perth, Australia)
| |
Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry
G. MacGregor, T. Hilliard, M. Imrie, J. A. Innes, A. C. Boyd, E. Alton, J. Davies, A. Bush, D. Porteous, A. P. Greening (Edinburgh, London, United Kingdom)
| |
Relationship between airway function in pre-school children with cystic fibrosis with that measured during infancy
W. Kozlowska, C. Saunders, S. Lum, P. Aurora, S. Ranganathan, R. Castle, C. Dezateux, J. Stocks (London, United Kingdom)
| |
Long-term repeatability of ventilation inhomogeneity in healthy infants and those with cystic fibrosis (CF)
H. K. Ljungberg, P. M. Gustafsson, G. Hülskamp, A. Hoo, S. Lum, J. J. Pillow, J. Stocks (London, United Kingdom; Göteborg, Sweden)
| |